The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Aromasin 25 mg coated tablets

Pfizer Healthcare IrelandPA0822/111/001

Main Information

Trade NameAromasin 25 mg coated tablets
Active SubstancesExemestane
Dosage FormCoated tablet
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/111/001

Group Information

ATC CodeL02BG Aromatase inhibitors
L02BG06 exemestane


License statusAuthorised
Licence Issued12/11/1999
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0142-022-040
Interchangeable List DocumentPDF of Interchangeable List
« Back